R
Richard E. Norman
Researcher at Birkbeck, University of London
Publications - 8
Citations - 292
Richard E. Norman is an academic researcher from Birkbeck, University of London. The author has contributed to research in topics: Cancer & Syllogism. The author has an hindex of 7, co-authored 8 publications receiving 288 citations.
Papers
More filters
Journal ArticleDOI
Studies of platinum(II) methionine complexes : metabolites of cisplatin
TL;DR: In this article, reactions of L-methionine (L-MetH) with [PtX 4 ] 2- (X=Cl, Br, I) in 1:1 and 2:1 mole ratios have been studied in aqueous solutions at pHs from 1.9 to 8.7 using 1 H, 13 C, 15 N, and 195 Pt NMR spectroscopy.
Journal ArticleDOI
Aristotle's philosopher-God
TL;DR: The Syllogistic Proof as mentioned in this paper is a simple statement of the syllogist proof, and it is not the meaning he intended to convey, but it has been interpreted as implying that the Prime Mover is a sort of heavenly Narcissus, who looks around for the perfection which he wishes to contemplate, finds nothing to rival his own self, and settles into a posture of permanent self-ad-verb.
Journal ArticleDOI
The autoxidation and proton dissociation constants of tertiary diphosphines: relevance to biological activity.
TL;DR: The pKas and autoxidation properties of a number of diphosphines which exhibit varying degrees of antitumor and cytotoxic activity were investigated and appeared to be independent of the substituents at the second phosphine center.
Journal ArticleDOI
Factors affecting 1H NMR spectra of blood plasma: cancer, diet and freezing.
TL;DR: Single pulse and Hahn spin‐echo 400 and 500 MHz 1H NMR spectra from normal subjects and cancer patients are reported and notable features of plasma spectra are discussed including resonances for ‘acute‐phase’ glycoproteins, ketone bodies and other small molecules.
Journal ArticleDOI
Nitrogen-14 NMR studies of amine release from platinum anticancer drugs: models and human blood plasma
TL;DR: The feasibility of using /sup 14/N(/sup 1/H) NMR spectroscopy to follow reactions of Pt(II) antitumor drugs under biologically relevant conditions has been investigated.